Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Maarten, Ooms"'
Autor:
Helena Koniar, Scott McNeil, Luke Wharton, Aidan Ingham, Michiel Van de Voorde, Maarten Ooms, Sathiya Sekar, Cristina Rodríguez-Rodríguez, Peter Kunz, Valery Radchenko, Arman Rahmim, Carlos Uribe, Hua Yang, Paul Schaffer
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-18 (2024)
Abstract Background Element-equivalent matched theranostic pairs facilitate quantitative in vivo imaging to establish pharmacokinetics and dosimetry estimates in the development of preclinical radiopharmaceuticals. Terbium radionuclides have signific
Externí odkaz:
https://doaj.org/article/94275ecfb96241b988df7d40866a532c
Autor:
Scott W. McNeil, Michiel Van de Voorde, Chengcheng Zhang, Maarten Ooms, François Bénard, Valery Radchenko, Hua Yang
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 7, Iss 1, Pp 1-17 (2022)
Abstract Background 161Tb is a radiolanthanide with the potential to replace 177Lu in targeted radionuclide therapy. 161Tb is produced via the neutron irradiation of [160Gd]Gd2O3 targets, and must be purified from 160Gd and the decay product 161Dy pr
Externí odkaz:
https://doaj.org/article/52199cec9dcf42fbae361825ab1fe278
Autor:
Dayana Castillo Seoane, Marijke De Saint-Hubert, Stephen Ahenkorah, Clarita Saldarriaga Vargas, Maarten Ooms, Lara Struelens, Michel Koole
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 7, Iss 1, Pp 1-17 (2022)
Abstract Background Quantification of actinium-225 through gamma counter measurements, when there is no secular equilibrium between actinium-225 and its gamma emitting daughters bismuth-213 and/or francium-221, can provide valuable information regard
Externí odkaz:
https://doaj.org/article/d6baddec1f944fb4b0f7e292790e2164
Autor:
Luke Wharton, Scott W. McNeil, Helen Merkens, Zheliang Yuan, Michiel Van de Voorde, Gokce Engudar, Aidan Ingham, Helena Koniar, Cristina Rodríguez-Rodríguez, Valery Radchenko, Maarten Ooms, Peter Kunz, François Bénard, Paul Schaffer, Hua Yang
Publikováno v:
Molecules, Vol 28, Iss 7, p 3155 (2023)
Terbium radioisotopes (149Tb, 152Tb, 155Tb, 161Tb) offer a unique class of radionuclides which encompass all four medicinally relevant nuclear decay modalities (α, β+, γ, β−/e−), and show high potential for the development of element-matched
Externí odkaz:
https://doaj.org/article/826b9ea67ada496da4b8a6e86da4e6ce
Autor:
Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, Amelie Coolkens, Sunay Rodriguez Pérez, Noami Daems, Charlotte Duchemin, Melissa Crabbé, Tomas Opsomer, Clarita Saldarriaga Vargas, Reinhard Heinke, Laura Lambert, Cyril Bernerd, Andrew R. Burgoyne, Thomas Elias Cocolios, Thierry Stora, Maarten Ooms
Publikováno v:
Pharmaceutics, Vol 14, Iss 12, p 2566 (2022)
Samarium-153 is a promising theranostic radionuclide, but low molar activities (Am) resulting from its current production route render it unsuitable for targeted radionuclide therapy (TRNT). Recent efforts combining neutron activation of 152Sm in the
Externí odkaz:
https://doaj.org/article/bf8a094d04184b509d6e9a3d216dfaea
Autor:
Irwin Cassells, Stephen Ahenkorah, Andrew R. Burgoyne, Michiel Van de Voorde, Christophe M. Deroose, Thomas Cardinaels, Guy Bormans, Maarten Ooms, Frederik Cleeren
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Targeted radionuclide therapy (TRNT) is a promising approach for cancer therapy. Terbium has four medically interesting isotopes (149Tb, 152Tb, 155Tb and 161Tb) which span the entire radiopharmaceutical space (TRNT, PET and SPECT imaging). Since the
Externí odkaz:
https://doaj.org/article/e73761dc31de4816bf35d8c9a5cf35b3
Autor:
Michiel Van de Voorde, Charlotte Duchemin, Reinhard Heinke, Laura Lambert, Eric Chevallay, Thomas Schneider, Miranda Van Stenis, Thomas Elias Cocolios, Thomas Cardinaels, Bernard Ponsard, Maarten Ooms, Thierry Stora, Andrew R. Burgoyne
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Samarium-153 (153Sm) is a highly interesting radionuclide within the field of targeted radionuclide therapy because of its favorable decay characteristics. 153Sm has a half-life of 1.93 d and decays into a stable daughter nuclide (153Eu) whereupon β
Externí odkaz:
https://doaj.org/article/4a450b7f4e2d4e3d8dce6029aafc6dd3
Autor:
Yuichi Wakabayashi, Per Stenkrona, Ryosuke Arakawa, Xuefeng Yan, Maia G. Van Buskirk, Madeline D. Jenkins, Jose A. Montero Santamaria, Kevin P. Maresca, Akihiro Takano, Jeih-San Liow, Thomas A. Chappie, Andrea Varrone, Sangram Nag, Lei Zhang, Zoë A. Hughes, Christopher J. Schmidt, Shawn D. Doran, Andrew Mannes, Paolo Zanotti-Fregonara, Maarten Ooms, Cheryl L. Morse, Sami S. Zoghbi, Christer Halldin, Victor W. Pike, Robert B. Innis
Publikováno v:
Journal of Nuclear Medicine. 63:1919-1924
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61c7d547cbcb5109418140c2b1e19428
https://doi.org/10.2967/jnumed.122.263838
https://doi.org/10.2967/jnumed.122.263838
Publikováno v:
ACS Applied Nano Materials. 5:8680-8709
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d9210db84641d45d49124733a6f83a0
https://doi.org/10.1021/acsanm.2c01204
https://doi.org/10.1021/acsanm.2c01204
Autor:
Stephen Ahenkorah, Irwin Cassells, Christophe M. Deroose, Thomas Cardinaels, Andrew R. Burgoyne, Guy Bormans, Maarten Ooms, Frederik Cleeren
Publikováno v:
Pharmaceutics, Vol 13, Iss 5, p 599 (2021)
In contrast to external high energy photon or proton therapy, targeted radionuclide therapy (TRNT) is a systemic cancer treatment allowing targeted irradiation of a primary tumor and all its metastases, resulting in less collateral damage to normal t
Externí odkaz:
https://doaj.org/article/53fe69a71bb745bdbf24088894bf1111